Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial ResultsBusiness Wire • 07/24/25
Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value InvestorsZacks Investment Research • 07/10/25
Fast-paced Momentum Stock Puma Biotech (PBYI) Is Still Trading at a BargainZacks Investment Research • 06/24/25
Despite Fast-paced Momentum, Puma Biotech (PBYI) Is Still a Bargain StockZacks Investment Research • 05/12/25
Puma Biotech (PBYI) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 04/30/25
Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer PatientsGlobeNewsWire • 04/30/25
Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025Business Wire • 04/28/25
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial ResultsBusiness Wire • 04/24/25
Is the Options Market Predicting a Spike in Puma Biotechnology Stock?Zacks Investment Research • 04/21/25
Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025Business Wire • 03/26/25
Puma Biotechnology to Present at Barclays Annual Global Healthcare ConferenceBusiness Wire • 03/05/25
Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial ResultsBusiness Wire • 02/27/25